Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.
Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D. Chakravorty S, et al. Among authors: parmar h. mBio. 2017 Aug 29;8(4):e00812-17. doi: 10.1128/mBio.00812-17. mBio. 2017. PMID: 28851844 Free PMC article.
Automatic Identification of Individual rpoB Gene Mutations Responsible for Rifampin Resistance in Mycobacterium tuberculosis by Use of Melting Temperature Signatures Generated by the Xpert MTB/RIF Ultra Assay.
Cao Y, Parmar H, Simmons AM, Kale D, Tong K, Lieu D, Persing D, Kwiatkowski R, Alland D, Chakravorty S. Cao Y, et al. Among authors: parmar h. J Clin Microbiol. 2019 Dec 23;58(1):e00907-19. doi: 10.1128/JCM.00907-19. Print 2019 Dec 23. J Clin Microbiol. 2019. PMID: 31533985 Free PMC article.
Xpert MTB/XDR: a 10-Color Reflex Assay Suitable for Point-of-Care Settings To Detect Isoniazid, Fluoroquinolone, and Second-Line-Injectable-Drug Resistance Directly from Mycobacterium tuberculosis-Positive Sputum.
Cao Y, Parmar H, Gaur RL, Lieu D, Raghunath S, Via N, Battaglia S, Cirillo DM, Denkinger C, Georghiou S, Kwiatkowski R, Persing D, Alland D, Chakravorty S. Cao Y, et al. Among authors: parmar h. J Clin Microbiol. 2021 Feb 18;59(3):e02314-20. doi: 10.1128/JCM.02314-20. Print 2021 Feb 18. J Clin Microbiol. 2021. PMID: 33298611 Free PMC article.
Analytical performance of the Xpert MTB/XDR® assay for tuberculosis and expanded resistance detection.
Georghiou SB, Penn-Nicholson A, de Vos M, Macé A, Syrmis MW, Jacob K, Mape A, Parmar H, Cao Y, Coulter C, Ruhwald M, Pandey SK, Schumacher SG, Denkinger CM. Georghiou SB, et al. Among authors: parmar h. Diagn Microbiol Infect Dis. 2021 Sep;101(1):115397. doi: 10.1016/j.diagmicrobio.2021.115397. Epub 2021 Apr 20. Diagn Microbiol Infect Dis. 2021. PMID: 34130215 Free article.
RT-PCR negative COVID-19.
Parmar H, Montovano M, Banada P, Pentakota SR, Shiau S, Ma Z, Saibire K, Chopoorian A, O'Shaughnessy M, Hirsch M, Jain P, Demirdjian G, Karagueuzian M, Robin T, Salvati M, Patel B, Alland D, Xie YL. Parmar H, et al. BMC Infect Dis. 2022 Feb 13;22(1):149. doi: 10.1186/s12879-022-07095-x. BMC Infect Dis. 2022. PMID: 35152885 Free PMC article.
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination.
Datta P, Ukey R, Bruiners N, Honnen W, Carayannopoulos MO, Reichman C, Choudhary A, Onyuka A, Handler D, Guerrini V, Mishra PK, Dewald HK, Lardizabal A, Lederer L, Leiser AL, Hussain S, Jagpal SK, Radbel J, Bhowmick T, Horton DB, Barrett ES, Xie YL, Fitzgerald-Bocarsly P, Weiss SH, Woortman M, Parmar H, Roy J, Dominguez-Bello MG, Blaser MJ, Carson JL, Panettieri RA Jr, Libutti SK, Raymond HF, Pinter A, Gennaro ML. Datta P, et al. Among authors: parmar h. J Immunol Methods. 2021 Dec;499:113165. doi: 10.1016/j.jim.2021.113165. Epub 2021 Oct 9. J Immunol Methods. 2021. PMID: 34634317 Free PMC article.
Real-world safety and efficacy of teclistamab in relapsed/refractory multiple myeloma: results from a multicenter, retrospective study and descriptive meta-analysis.
Varma G, Fogel L, Gordon B, Saldarriaga MM, Ahn J, Aleman A, Caro J, Rosenberg MC, Monge J, Parmar H, Kaminetzky D, Moskovits T, Siegel DS, Morgan GJ, Niesvizky R, Davies FE, Biran N. Varma G, et al. Among authors: parmar h. Leuk Lymphoma. 2025 Jan 5:1-10. doi: 10.1080/10428194.2024.2446617. Online ahead of print. Leuk Lymphoma. 2025. PMID: 39756041
Pneumococcal pneumonia trends in adults hospitalised with community-acquired pneumonia over 10 years (2013-2023) and the role of serotype 3.
Lansbury L, McKeever TM, Lawrence H, Pick H, Baskaran V, Edwards-Pritchard R, Matthews L, Bailey H, Ashton D, Bendall L, Rodrigo C, Daniel P, Litt D, Eletu S, Parmar H, Sheppard C, Ladhani SN, Trotter C, Lim WS. Lansbury L, et al. Among authors: parmar h. Thorax. 2024 Dec 12:thorax-2024-221976. doi: 10.1136/thorax-2024-221976. Online ahead of print. Thorax. 2024. PMID: 39667904
316 results